Đang chuẩn bị liên kết để tải về tài liệu:
CLINICAL PHARMACOLOGY 2003 (PART 3)

Appendix hTheWorld Health Organization model list of essential drugs' We reprint the current list (by permission). Whilst the WHO programme (revised 1999) was instituted particularly to help less developed countries, the list has interest and lessons for all societies facing, as they now are, the problems of delivering economically affordable health care to all. We commend a study of the list to our readers (see also p. 18). The list of essential drugs may be considered against the background of the available marketed medicines worldwide. Any national or local group of health workers wishing to produce a formulary to provide. | SECTION I TOPICS IN DRUG THERAPY Appendix kTheWorld Health Organization model list of essential drugs1 We reprint the current list by permission . Whilst the WHO programme revised 1999 was instituted particularly to help less developed countries the list has interest and lessons for all societies facing as they now are the problems of delivering economically affordable health care to all. We commend a study of the list to our readers see also p. 18 . The list of essential drugs may be considered against the background of the available marketed medicines worldwide. Any national or local group of health workers wishing to produce a formulary to provide for the needs of their own community would be well advised to study the current version in addition to other sources. A major standard reference work Martindale 1996 The extra pharmacopoeia. 31st edn. Pharmaceutical Press London describes 62500 preparations or groups of preparations from 17 different countries. 1 WHO Drug Information Vol 13 No 4 1999 Explanatory notes We print the list in full. Drugs marked represent an example of a therapeutic group i.e. various other drugs could serve as an alternative say on cost grounds. Complementary drugs are for use where for any reason drugs in the main list are unavailable or there are exceptional medical circumstances e.g. bacterial resistance rare disorders. Spelling of drug names. The World Health Organization devises recommended International Nonproprietary Names rINN . These are becoming universal most do not give rise to any confusion but occasionally we insert an alternative name or spelling. Not every entry in the list is discussed in this book. Conversely the book may give drug treatments for specific conditions that differ from those listed here. I. Anaesthetics 1.1 General anaesthetics and oxygen ether anaesthetic halothane ketamine nitrous oxide oxygen thiopental 1.2 Local anaesthetics bupivacaine lidocaine lignocaine COMPLEMENTARY DRUG ephedrine in spinal .